CytoCore, Inc.
414 North Orleans Street
Suite 510
Chicago,
IL 60654
United States - Map
Phone: 312-222-9550
Fax: 312-222-9580
Web Site: http://www.cytocoreinc.com
| Cytocore Inc. develops, manufactures, and sells an integrated family of products for the detection, diagnosis, and treatment of cancer under CytoCore Solutions trade name. The company offers its CytoCore Solutions products primarily for cervical cancer, and to address the sample collection, specimen preparation, and patient treatment and monitoring, as well as for specimen evaluation, including detection/screening and diagnosis related to specific cancers. Its cell collection devices include SoftPAP, a cell collection device for the collection of cervical cell samples that are used in the detection of cervical dysplasia, cancer, and HPV infections; and PadKit, a sample collection device that captures a sample to be evaluated to provide an assessment of the health of the female genital tract. The companys specimen preparation products comprise GluCyte, a cell preservative and methodology that provides a means for laboratories to transition from smears to LBPs; and stains and reagents for use in cervical cytology and other screening applications. Its specimen evaluation products consists of AIPS workstation to address the root causes of various ergonomic problems; AIPS Imager, a medical screening program to differentiate between patients who show no evidence of the target disease state and those who do; and OmniDROP, a communicator software that is provided as a software-as-a-service product for AIPS systems, as well as for laboratories, hospitals, and health maintenance organizations. In addition, the company develops a derivative of the SoftPAP cell collection device to apply a patch containing a therapeutic agent to the cervix. The company was formerly known as Molecular Diagnostics, Inc. and changed its name to Cytocore Inc. in 2006. The company is based in Chicago, Illinois. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Robert F. McCullough Jr., 54
Chairman, Chief Exec. Officer, Chief Financial Officer and Principal Accounting Officer |
$
180.00K |
$
0 | Dr. Richard A. Domanik Ph.D., 62
Chief Operating Officer |
$
145.00K |
$
0 | Dr. George Gorodeski M.D., M.Sc., Ph.D.,
Consultant, Lead Research Scientist and Head of Medical Advisory Board |
N/A
| N/A | Dr. Michael Jolley Ph.D.,
Director of Assay Devel. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.51% Nasdaq 
Profile
